Cargando…
Adults with Crohn’s disease exhibit elevated gynoid fat and reduced android fat irrespective of disease relapse or remission
Crohn’s disease (CD) is a debilitating inflammatory bowel condition of unknown aetiology that is growing in prevalence globally. Large-scale studies have determined associations between female obesity or low body mass index (BMI) with risk of CD at all ages or 8– < 40 years, respectively. For mal...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479075/ https://www.ncbi.nlm.nih.gov/pubmed/34584177 http://dx.doi.org/10.1038/s41598-021-98798-9 |
_version_ | 1784576168134967296 |
---|---|
author | Dowling, Lisa Jakeman, Philip Norton, Catherine Skelly, Maeve M. Yousuf, Hamid Kiernan, Miranda G. Toomey, Margaret Bowers, Sheila Dunne, Suzanne S. Coffey, J. Calvin Dunne, Colum P. |
author_facet | Dowling, Lisa Jakeman, Philip Norton, Catherine Skelly, Maeve M. Yousuf, Hamid Kiernan, Miranda G. Toomey, Margaret Bowers, Sheila Dunne, Suzanne S. Coffey, J. Calvin Dunne, Colum P. |
author_sort | Dowling, Lisa |
collection | PubMed |
description | Crohn’s disease (CD) is a debilitating inflammatory bowel condition of unknown aetiology that is growing in prevalence globally. Large-scale studies have determined associations between female obesity or low body mass index (BMI) with risk of CD at all ages or 8– < 40 years, respectively. For males, low BMI entering adult life is associated with increased incidence of CD or ulcerative colitis up to 40 years later. Body composition analysis has shown that combinations of lean tissue loss and high visceral fat predict poor CD outcomes. Here, we assessed dietary intake, physical activity and whole or regional body composition of patients with CD relapse or remission. This anthropometric approach found people with CD, irrespective of relapse or remission, differed from a large representative healthy population sample in exhibiting elevated gynoid fat and reduced android fat. CD is associated with mesenteric adipose tissue, or “creeping fat”, that envelops affected intestine exclusive of other tissue; that fat is localised to the android region of the body. In this context, CD mesenteric adiposity represents a stark juxtaposition of organ-specific and regional adiposity. Although our study population was relatively small, we suggest tentatively that there is a rationale to refer to Crohn’s disease as a fatty intestine condition, akin to fatty liver conditions. We suggest that our data provide early insight into a subject that potentially warrants further investigation across a larger patient cohort. |
format | Online Article Text |
id | pubmed-8479075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-84790752021-09-30 Adults with Crohn’s disease exhibit elevated gynoid fat and reduced android fat irrespective of disease relapse or remission Dowling, Lisa Jakeman, Philip Norton, Catherine Skelly, Maeve M. Yousuf, Hamid Kiernan, Miranda G. Toomey, Margaret Bowers, Sheila Dunne, Suzanne S. Coffey, J. Calvin Dunne, Colum P. Sci Rep Article Crohn’s disease (CD) is a debilitating inflammatory bowel condition of unknown aetiology that is growing in prevalence globally. Large-scale studies have determined associations between female obesity or low body mass index (BMI) with risk of CD at all ages or 8– < 40 years, respectively. For males, low BMI entering adult life is associated with increased incidence of CD or ulcerative colitis up to 40 years later. Body composition analysis has shown that combinations of lean tissue loss and high visceral fat predict poor CD outcomes. Here, we assessed dietary intake, physical activity and whole or regional body composition of patients with CD relapse or remission. This anthropometric approach found people with CD, irrespective of relapse or remission, differed from a large representative healthy population sample in exhibiting elevated gynoid fat and reduced android fat. CD is associated with mesenteric adipose tissue, or “creeping fat”, that envelops affected intestine exclusive of other tissue; that fat is localised to the android region of the body. In this context, CD mesenteric adiposity represents a stark juxtaposition of organ-specific and regional adiposity. Although our study population was relatively small, we suggest tentatively that there is a rationale to refer to Crohn’s disease as a fatty intestine condition, akin to fatty liver conditions. We suggest that our data provide early insight into a subject that potentially warrants further investigation across a larger patient cohort. Nature Publishing Group UK 2021-09-28 /pmc/articles/PMC8479075/ /pubmed/34584177 http://dx.doi.org/10.1038/s41598-021-98798-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Dowling, Lisa Jakeman, Philip Norton, Catherine Skelly, Maeve M. Yousuf, Hamid Kiernan, Miranda G. Toomey, Margaret Bowers, Sheila Dunne, Suzanne S. Coffey, J. Calvin Dunne, Colum P. Adults with Crohn’s disease exhibit elevated gynoid fat and reduced android fat irrespective of disease relapse or remission |
title | Adults with Crohn’s disease exhibit elevated gynoid fat and reduced android fat irrespective of disease relapse or remission |
title_full | Adults with Crohn’s disease exhibit elevated gynoid fat and reduced android fat irrespective of disease relapse or remission |
title_fullStr | Adults with Crohn’s disease exhibit elevated gynoid fat and reduced android fat irrespective of disease relapse or remission |
title_full_unstemmed | Adults with Crohn’s disease exhibit elevated gynoid fat and reduced android fat irrespective of disease relapse or remission |
title_short | Adults with Crohn’s disease exhibit elevated gynoid fat and reduced android fat irrespective of disease relapse or remission |
title_sort | adults with crohn’s disease exhibit elevated gynoid fat and reduced android fat irrespective of disease relapse or remission |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479075/ https://www.ncbi.nlm.nih.gov/pubmed/34584177 http://dx.doi.org/10.1038/s41598-021-98798-9 |
work_keys_str_mv | AT dowlinglisa adultswithcrohnsdiseaseexhibitelevatedgynoidfatandreducedandroidfatirrespectiveofdiseaserelapseorremission AT jakemanphilip adultswithcrohnsdiseaseexhibitelevatedgynoidfatandreducedandroidfatirrespectiveofdiseaserelapseorremission AT nortoncatherine adultswithcrohnsdiseaseexhibitelevatedgynoidfatandreducedandroidfatirrespectiveofdiseaserelapseorremission AT skellymaevem adultswithcrohnsdiseaseexhibitelevatedgynoidfatandreducedandroidfatirrespectiveofdiseaserelapseorremission AT yousufhamid adultswithcrohnsdiseaseexhibitelevatedgynoidfatandreducedandroidfatirrespectiveofdiseaserelapseorremission AT kiernanmirandag adultswithcrohnsdiseaseexhibitelevatedgynoidfatandreducedandroidfatirrespectiveofdiseaserelapseorremission AT toomeymargaret adultswithcrohnsdiseaseexhibitelevatedgynoidfatandreducedandroidfatirrespectiveofdiseaserelapseorremission AT bowerssheila adultswithcrohnsdiseaseexhibitelevatedgynoidfatandreducedandroidfatirrespectiveofdiseaserelapseorremission AT dunnesuzannes adultswithcrohnsdiseaseexhibitelevatedgynoidfatandreducedandroidfatirrespectiveofdiseaserelapseorremission AT coffeyjcalvin adultswithcrohnsdiseaseexhibitelevatedgynoidfatandreducedandroidfatirrespectiveofdiseaserelapseorremission AT dunnecolump adultswithcrohnsdiseaseexhibitelevatedgynoidfatandreducedandroidfatirrespectiveofdiseaserelapseorremission |